{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T02:40:14Z","timestamp":1682822414448},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jviromet.2004.09.013","type":"journal-article","created":{"date-parts":[[2004,11,8]],"date-time":"2004-11-08T18:47:18Z","timestamp":1099939638000},"page":"131-140","source":"Crossref","is-referenced-by-count":3,"title":["Establishment of an alternative intracellular cytokine staining assay for HIV\/AIDS clinical studies"],"prefix":"10.1016","volume":"123","author":[{"given":"Huiyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Reichman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Keefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2004.09.013_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/JVI.77.3.2081-2092.2003","article-title":"Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load","volume":"77","author":"Addo","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2004.09.013_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.192.1.63","article-title":"HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function","volume":"192","author":"Appay","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2004.09.013_bib4","doi-asserted-by":"crossref","first-page":"11983","DOI":"10.1128\/JVI.75.24.11983-11991.2001","article-title":"Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection","volume":"75","author":"Betts","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib5","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1128\/JVI.74.19.9144-9151.2000","article-title":"Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype","volume":"74","author":"Betts","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib6","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.162.3.1765","article-title":"Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2\/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy","volume":"162","author":"Bieganowska","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(00)80469-0","article-title":"Massive expansion of antigen-specific CD8+ T cells during an acute virus infection","volume":"8","author":"Butz","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jviromet.2004.09.013_bib8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2004.09.013_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1084\/jem.177.2.249","article-title":"Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease","volume":"177","author":"Carmichael","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2004.09.013_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-1759(02)00541-0","article-title":"Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses","volume":"275","author":"Draenert","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2004.09.013_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-2478(01)00173-0","article-title":"Evaluation of canarypox-induced CD8(+) responses following immunization by measuring the effector population IFNgamma production","volume":"77","author":"Evans","year":"2001","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jviromet.2004.09.013_bib12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.4049\/jimmunol.165.2.1082","article-title":"Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors","volume":"165","author":"Gea_Banacloche","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/35085576","article-title":"Evolution and transmission of stable CTL escape mutations in HIV infection","volume":"412","author":"Goulder","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2004.09.013_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nm0297-212","article-title":"Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS","volume":"3","author":"Goulder","year":"1997","journal-title":"Nat. Med."},{"issue":"Pt 5","key":"10.1016\/j.jviromet.2004.09.013_bib15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1099\/0022-1317-72-5-1183","article-title":"Human cytotoxic T cell responses to vaccinia virus vaccination","volume":"72","author":"Graham","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib16","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.162.3.1780","article-title":"Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)","volume":"162","author":"Gray","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2004.09.013_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/315201","article-title":"High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections","volume":"181","author":"Jin","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2004.09.013_bib19","series-title":"Proceedings of the 7th Conference on Retroviruses and Opportunistic Infections","article-title":"Discontinuation of HAART after a course of therapeutic vaccination with ALVAC vCP1452 and recombinant gp160 may be associated with delayed viral rebound kinetics","author":"Jin","year":"2000"},{"key":"10.1016\/j.jviromet.2004.09.013_bib20","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/jvi.76.5.2206-2216.2002","article-title":"Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy","volume":"76","author":"Jin","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib21","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1128\/JVI.73.8.6721-6728.1999","article-title":"Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy","volume":"73","author":"Kalams","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.181.4.1365","article-title":"Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics","volume":"181","author":"Klein","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2004.09.013_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0022-1759(92)90143-H","article-title":"Analysis of B lymphocyte cross-reactivity at the single cell level","volume":"152","author":"Klinman","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2004.09.013_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.186.6.859","article-title":"Rapid effector function in CD8+ memory T cells","volume":"186","author":"Lalvani","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2004.09.013_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-199905070-00005","article-title":"A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals","volume":"13","author":"Larsson","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2004.09.013_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/08892220050042846","article-title":"A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group","volume":"16","author":"McElrath","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jviromet.2004.09.013_bib27","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.191.11.1921","article-title":"Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine","volume":"191","author":"Metzner","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2004.09.013_bib28","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1073\/pnas.050567397","article-title":"HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors","volume":"97","author":"Migueles","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2004.09.013_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","article-title":"Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection","volume":"8","author":"Murali_Krishna","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jviromet.2004.09.013_bib30","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","article-title":"Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA","volume":"279","author":"Ogg","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2004.09.013_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/JVI.73.1.797-800.1999","article-title":"Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy","volume":"73","author":"Ogg","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/354453a0","article-title":"Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition","volume":"354","author":"Phillips","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2004.09.013_bib33","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1128\/JVI.69.9.5838-5842.1995","article-title":"High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors","volume":"69","author":"Rinaldo","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/367702","article-title":"Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity","volume":"187","author":"Russell","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2004.09.013_bib35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2004.09.013_bib36","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1086\/315860","article-title":"Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214","volume":"182","author":"Schooley","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2004.09.013_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-1759(02)00328-9","article-title":"A systematic comparison of methods to measure HIV-1 specific CD8 T cells","volume":"272","author":"Sun","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2004.09.013_bib38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20022222","article-title":"Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses","volume":"197","author":"Terajima","year":"2003","journal-title":"J. Exp. Med."},{"issue":"Pt 8","key":"10.1016\/j.jviromet.2004.09.013_bib39","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1099\/0022-1317-78-8-1913","article-title":"Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS","volume":"78","author":"van_Baalen","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2004.09.013_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-1759(03)00064-4","article-title":"Vaccinia assay for the rapid detection of functional HIV-specific CD8(+) cytotoxic T lymphocytes","volume":"276","author":"Xu","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2004.09.013_bib41","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function.","volume":"188","author":"Zajac","year":"1998","journal-title":"J. Exp. Med."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093404002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093404002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T02:01:04Z","timestamp":1682820064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093404002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0166093404002800"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2004.09.013","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}